15616669|t|Glutamate in CNS disorders as a target for drug development: an update.
15616669|a|The authors provide an extensive review of new data related to the role of glutamate in CNS disorders, describing new aspects in glutamate and glutamatergic receptors-NMDA receptors, NR2B-selective antagonists, non-NMDA ionotropic glutamate receptors, N-acetylaspartylglutamate, and glutamate and glycine transporters. New findings in animal models and in human diseases-stroke, traumatic brain injury, Alzheimer's, Parkinson's and Huntington's diseases, tardive dyskinesia, ALS, olivopontcerebellar degeneration, AIDS, allergic encephalomyelitis, epilepsy, anxiety, depression, schizophrenia, liver disease, aminoglycoside antibiotic-induced hearing loss, hemiplegia, chronic pain and drug tolerance and abuse-are presented. Finally, the authors cite the progress achieved in the development of agents that interact with the glutamatergic system: NMDA channel blockers, competitive NMDA receptor antagonists, NR2B-selective antagonists, glutamate release inhibitors, glycineB antagonists, AMPA and kainate receptor antagonists, AMPA receptor-positive modulators and agents that act by modifying endogenous kynurenic acid metabolism.
15616669	0	9	Glutamate	Chemical	MESH:D018698
15616669	13	26	CNS disorders	Disease	MESH:D002494
15616669	147	156	glutamate	Chemical	MESH:D018698
15616669	160	173	CNS disorders	Disease	MESH:D002494
15616669	255	259	NR2B	Gene	2904
15616669	428	433	human	Species	9606
15616669	443	449	stroke	Disease	MESH:D020521
15616669	451	473	traumatic brain injury	Disease	MESH:D000070642
15616669	475	486	Alzheimer's	Disease	MESH:D000544
15616669	488	499	Parkinson's	Disease	MESH:D010300
15616669	504	525	Huntington's diseases	Disease	MESH:D006816
15616669	527	545	tardive dyskinesia	Disease	MESH:D004409
15616669	547	550	ALS	Disease	MESH:D008113
15616669	552	584	olivopontcerebellar degeneration	Disease	MESH:D009410
15616669	586	590	AIDS	Disease	MESH:D000163
15616669	592	618	allergic encephalomyelitis	Disease	MESH:D004681
15616669	620	628	epilepsy	Disease	MESH:D004827
15616669	630	637	anxiety	Disease	MESH:D001007
15616669	639	649	depression	Disease	MESH:D003866
15616669	651	664	schizophrenia	Disease	MESH:D012559
15616669	666	679	liver disease	Disease	MESH:D008107
15616669	681	695	aminoglycoside	Chemical	MESH:D000617
15616669	715	727	hearing loss	Disease	MESH:D034381
15616669	729	739	hemiplegia	Disease	MESH:D006429
15616669	741	753	chronic pain	Disease	MESH:D059350
15616669	758	772	drug tolerance	Disease	MESH:D000081015
15616669	982	986	NR2B	Gene	2904
15616669	1010	1019	glutamate	Chemical	MESH:D018698
15616669	1040	1048	glycineB	Chemical	-
15616669	1179	1193	kynurenic acid	Chemical	MESH:D007736
15616669	Association	MESH:D018698	MESH:D002494
15616669	Positive_Correlation	MESH:D000617	MESH:D034381

